Orthofix Medical Inc. - Common Stock (OFIX)

OFIX stock results show that Orthofix Medical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

The company had a big leadership change after an investigation.

Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook.

OFIX stock results show that Orthofix Medical met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

OFIX stock results show that Orthofix Medical missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.

U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday.

U.S. stock futures traded lower this morning, with the Dow Jones futures falling more than 50 points on Monday.

The ride-hailing giant will join the index as part of a quarterly rebalancing.

Gainers Tenon Medical, Inc. (NASDAQ: TNON) shares climbed 63.5% to $0.2351 after the company announced it has withdrawn its proposed public offering of shares of its common stock.

U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss.